Adma Biologics (ADMA) Revenue Growth (3y) (2015 - 2025)
Adma Biologics (ADMA) Revenue Growth (3y) (2015 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,184.45 Bn | 68,184.17 Bn | - | - |
| 2 | Nanobiotix | 1,953.19 Bn | 1,953.13 Bn | - | - |
| 3 | Akari Therapeutics | 1,132.35 Bn | 1,132.35 Bn | - | - |
| 4 | BeOne Medicines | 474.39 Bn | 469.59 Bn | 1.35 Bn | 50.07% |
| 5 | Vertex Pharmaceuticals | 123.45 Bn | 116.21 Bn | 2.59 Bn | 7.94% |
| 6 | Regeneron Pharmaceuticals | 69.92 Bn | 61.16 Bn | 3.31 Bn | 4.47% |
| 7 | Belite Bio | 63.43 Bn | 63.43 Bn | - | - |
| 8 | Argenx Se | 56.67 Bn | 51.49 Bn | 1.41 Bn | 79.44% |
| 9 | Revolution Medicines | 38.08 Bn | 38.08 Bn | - | - |
| 10 | Adma Biologics | 2.00 Bn | 1.91 Bn | 88.82 Mn | 40.68% |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 40.68% |
| Sep 30, 2025 | 48.38% |
| Jun 30, 2025 | 17.60% |
| Mar 31, 2025 | 58.00% |
| Dec 31, 2024 | 28.81% |
| Sep 30, 2024 | 79.62% |
| Jun 30, 2024 | 81.83% |
| Mar 31, 2024 | 72.15% |
| Dec 31, 2023 | 74.30% |
| Sep 30, 2023 | 120.39% |
| Jun 30, 2023 | 97.64% |
| Mar 31, 2023 | 77.37% |
| Dec 31, 2022 | 60.89% |
| Sep 30, 2022 | 78.52% |
| Jun 30, 2022 | 120.46% |
| Mar 31, 2022 | 102.04% |
| Dec 31, 2021 | 138.46% |
| Sep 30, 2021 | 69.72% |
| Jun 30, 2021 | 56.85% |
| Mar 31, 2021 | 58.82% |